STK11 and neoplasm: In our study, all three patients with mutations in STK11 demonstrated tumor shrinkage and had a missense mutation at amino acid 354, leading to conversion of the wild-type residue phenylalanine to a leucine (STK11, p.F354L, c.1062C > G).